1. Home
  2. UONEK vs MRKR Comparison

UONEK vs MRKR Comparison

Compare UONEK & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Urban One Inc. Class D

UONEK

Urban One Inc. Class D

HOLD

Current Price

$3.66

Market Cap

19.9M

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$0.98

Market Cap

19.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UONEK
MRKR
Founded
1979
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.9M
19.5M
IPO Year
1999
2010

Fundamental Metrics

Financial Performance
Metric
UONEK
MRKR
Price
$3.66
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $7.87
AVG Volume (30 Days)
8.0K
★ 162.3K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 33.61
EPS
N/A
★ N/A
Revenue
★ $439,098,000.00
N/A
Revenue This Year
N/A
$19.61
Revenue Next Year
N/A
$375.85
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.76
$0.84
52 Week High
$10.90
$2.46

Technical Indicators

Market Signals
Indicator
UONEK
MRKR
Relative Strength Index (RSI) 40.58 43.06
Support Level $3.51 $0.88
Resistance Level $4.42 $1.34
Average True Range (ATR) 0.24 0.10
MACD 0.01 0.01
Stochastic Oscillator 13.10 26.97

Price Performance

Historical Comparison
UONEK
MRKR

About UONEK Urban One Inc. Class D

Urban One Inc is an urban oriented, multi-media company. Its business is radio broadcasting franchise that is the radio broadcasting operation that targets African-American and urban listeners. It operates through the following segments: Radio Broadcasting, Reach Media, Digital, and Cable Television. The Radio Broadcasting segment includes all the broadcasting related operations. The Reach Media segment consists of the Tom Joyner Morning Show and its related activities. The Digital segment focuses on its online business, including the operations of Interactive One. The Cable Television segment deals with TV One's operations.

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from MAR-T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells. These T cells are designed to recognize multiple tumor targets to produce broad spectrum anti-tumor activity. Its pipeline products include: Autologous MAR-T cell product for the treatment of lymphoma and pancreatic cancer (MT-601), and Off-the-Shelf (OTS) products (MT-401-OTS).

Share on Social Networks: